Injection, Suspension · Intramuscular

Influenza A Virus A/Switzerland/6849/2025 Ivr-278 (A/Missouri/11/2025 Pdm09-Like Virus) (H1n1) Antigen (Formaldehyde Inactivated), Influenza A Virus A/Michigan/105/2025 San-049a (H3n2) Antigen (Formaldehyde Inactivated), And Influenza B Virus B/Tokyo/Eis13-175/2025 Antigen (Formaldehyde Inactivated)

Brands: Fluzone High Dose Northern Hemisphere · Influenza A Virus A/Michigan/105/2025 San-049a (H3n2) Antigen (Formaldehyde Inactivated) + Influenza A Virus A/Switzerland/6849/2025 Ivr-278 (H1n1) Antigen (Formaldehyde Inactivated) + Influenza B Virus B/Tokyo/Eis13-175/2025 Antigen (Formaldehyde Inactivated)

0 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US1 NDCs
0 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)2740124

US makers1 labelers

Packages1

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Sanofi Vaccines US Inc.	unknown	1	EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.